当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 现金流量表

天康生物

(002100)

  

流通市值:101.85亿  总市值:101.85亿
流通股本:13.65亿   总股本:13.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金13,298,965,198.778,780,079,803.674,109,853,860.6418,388,189,563.59
  收到的税费返还831,975.87--186,573.06
  收到其他与经营活动有关的现金74,026,164.7840,870,453.3925,771,866.74325,408,916.27
  经营活动现金流入小计13,373,823,339.428,820,950,257.064,135,625,727.3818,713,785,052.92
  购买商品、接受劳务支付的现金9,767,523,724.086,199,354,467.433,608,282,340.5515,892,688,152.19
  支付给职工以及为职工支付的现金578,269,789.55455,601,245.12213,539,576.71922,142,850.05
  支付的各项税费120,561,124.675,917,849.0634,909,596.64191,566,113.81
  支付其他与经营活动有关的现金556,889,670.68471,051,234.09154,849,787.18545,522,630.55
  经营活动现金流出小计11,023,244,308.917,201,924,795.74,011,581,301.0817,551,919,746.6
  经营活动产生的现金流量净额2,350,579,030.511,619,025,461.36124,044,426.31,161,865,306.32
二、投资活动产生的现金流量:
  收回投资收到的现金---49,000,000
  取得投资收益收到的现金---91,124.24
  处置固定资产、无形资产和其他长期资产收回的现金净额686,699.99686,699.99-6,352,672.95
  投资活动现金流入小计686,699.99686,699.99055,443,797.19
  购建固定资产、无形资产和其他长期资产支付的现金243,060,965.55179,118,903.5172,139,359.2626,462,554.36
  投资支付的现金---179,000,000
  投资活动现金流出小计243,060,965.55179,118,903.5172,139,359.2805,462,554.36
  投资活动产生的现金流量净额-242,374,265.56-178,432,203.52-72,139,359.2-750,018,757.17
三、筹资活动产生的现金流量:
  吸收投资收到的现金---42,350,000
  其中:子公司吸收少数股东投资收到的现金---42,350,000
  取得借款收到的现金3,416,687,240.221,270,987,240.221,180,253,285.96,820,142,722.4
  收到其他与筹资活动有关的现金---680,520
  筹资活动现金流入小计3,416,687,240.221,270,987,240.221,180,253,285.96,863,173,242.4
  偿还债务支付的现金4,143,822,504.22,474,714,726.361,067,710,0006,702,103,726.34
  分配股利、利润或偿付利息支付的现金493,635,228.87380,793,238.339,756,510.02207,597,522.61
  其中:子公司支付给少数股东的股利、利润---34,276,475.6
  支付其他与筹资活动有关的现金---84,341,092.12
  筹资活动现金流出小计4,637,457,733.072,855,507,964.661,107,466,510.026,994,042,341.07
  筹资活动产生的现金流量净额-1,220,770,492.85-1,584,520,724.4472,786,775.88-130,869,098.67
五、现金及现金等价物净增加额887,434,272.1-143,927,466.6124,691,842.98280,977,450.48
  加:期初现金及现金等价物余额2,672,585,099.422,953,562,549.92,953,562,549.92,672,585,099.42
  期末现金及现金等价物余额3,560,019,371.522,809,635,083.33,078,254,392.882,953,562,549.9
补充资料:
  净利润-409,618,129.4-596,421,188.04
  资产减值准备-29,163,891.72-22,737,961.15
  固定资产和投资性房地产折旧-344,520,747.08-685,161,599.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-344,520,747.08-685,161,599.31
  无形资产摊销-12,828,955.69-25,938,333.19
  长期待摊费用摊销-8,718,740.07-13,054,566.92
  处置固定资产、无形资产和其他长期资产的损失-423,913.1--4,500,658.4
  固定资产报废损失-36,962,429.05-28,459,691.97
  公允价值变动损失--44,621.09--50,872.22
  财务费用-80,437,905-178,940,936.76
  投资损失-7,276,145.63-1,917,176.15
  递延所得税--16,150,641.1--27,473,885.41
  其中:递延所得税资产减少--16,057,576.05--26,961,341.66
    递延所得税负债增加--93,065.05--512,543.75
  存货的减少-808,724,105.36-367,898,428.35
  经营性应收项目的减少-177,525,348.85--605,881,091.91
  经营性应付项目的增加--365,454,339.01-9,475,486.01
  其他----307,661,455.19
  现金的期末余额-2,809,635,083.3-2,953,562,549.9
  减:现金的期初余额-2,953,562,549.9-2,672,585,099.42
  现金及现金等价物的净增加额--143,927,466.6-280,977,450.48
公告日期2025-10-302025-08-302025-04-302025-04-29
审计意见(境内)标准无保留意见
TOP↑